Maze Therapeutics, Inc. employees and revenue per employee

MAZE · Biotechnology · $1.50B market cap

Maze Therapeutics, Inc. had 125 employees at the end of fiscal Dec 2024. Revenue for the year was $168M, or $1.34M per employee.

Employees

125

Revenue

$168M

Revenue / employee

$1.34M

Peer median $459K

Rank in industry

24 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

Only one fiscal year on file so far, so there is no trend to draw yet.

Employees, last six fiscal years
125'24
Revenue per employee, last six fiscal years
$1.34M'24

Maze Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
MAZE
Maze Therapeutics, Inc.
125$168M$1.34M—
STOK
Stoke Therapeutics, Inc.
170$184M$1.08MEfficient growth
SNDX
Syndax Pharmaceuticals, Inc.
298$172M$578KEfficient growth
PHAT
Phathom Pharmaceuticals, Inc.
371$175M$472KLeaner
RGNX
REGENXBIO Inc.
371$170M$459KEfficient growth
RYTM
Rhythm Pharmaceuticals, Inc.
414$190M$458KHiring ahead
MRVI
Maravai LifeSciences Holdings, Inc.
435$186M$427KContracting
DNA
Ginkgo Bioworks Holdings, Inc.
485$170M$351KContracting
BEAM
Beam Therapeutics Inc.
511$140M$273KEfficient growth
Every Healthcare company

Questions about Maze Therapeutics, Inc.

How many employees does Maze Therapeutics, Inc. have?
Maze Therapeutics, Inc. reported 125 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 31, 2025.
What is Maze Therapeutics, Inc.'s revenue per employee?
Maze Therapeutics, Inc. brought in $168M of revenue in fiscal Dec 2024, which is $1.34M per employee. That ranks 24 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare MAZE with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Maze Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 31, 2025. This is data, not a recommendation to buy or sell MAZE.